Collegium Pharmaceutical, Inc. COLL

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-02 · statements 2025-12-31

Average Intrinsic Value
$583.24M
Market Cap
$748.22M
Margin of Safety
-28.3%
Intrinsic / Market Ratio
0.78

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

734.24M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

907.79M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

107.70M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

583.24M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

583.24M USD

from the sum above

Market Cap

748.22M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.78×

the ratio the screener ranks by; Margin of Safety -28.3% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 734.24M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.70B USD
−②Net Debt Today968.03M USD
+③Growth Value0 USD
=Value734.24M USD

EPV of the Operations (NOPAT over WACC)

1.70B USD

Net debt today

-968.03M USD

Growth Value

0 USD

Value

734.24M USD

①EPV (earnings power value)

1.70B USD

②Net Debt Today

968.03M USD

③Growth Value

0 USD

Market value

Market Cap748.22M USD

Today's price times the shares.

Value vs market

Margin of Safety-1.9%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 907.79M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE703.21M USD
+②Equity at Year 15, Today204.58M USD
=Value907.79M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

703.21M USD

②Equity at Year 15, Today

204.58M USD

Market value

Market Cap748.22M USD

Today's price times the shares.

Value vs market

Margin of Safety+17.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 107.70M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF755.35M USD
+②Invested Capital at Year 15, Today320.38M USD
−③Net Debt Today968.03M USD
=Value107.70M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

755.35M USD

②Invested Capital at Year 15, Today

320.38M USD

③Net Debt Today

968.03M USD

Market value

Market Cap748.22M USD

Today's price times the shares.

Value vs market

Margin of Safety-594.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.63%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.73×Market Risk Premium 6.00%= 8.88%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 29.78M USDPretax Income 92.71M USD= 32.12%

The tax the interest saves.

Interest Expense =EBIT 175.11M USD−Pretax Income 92.71M USD= 82.39M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 82.39M USDTotal Debt 1.10B USD×(1 − Tax Rate for WACC 32.12%)= 5.10%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.10B USDMarket Cap + Total Debt 748.22M USD + 1.10B USD= 59.46%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 40.54%×Cost of Equity 8.88%+Debt Weight 59.46%×Cost of Debt 5.10%= 6.63%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 2.14B USD − Total Liabilities 1.83B USD = Book Value Today 312.22M USD

Total Debt 1.10B USD − Cash and Short-Term Investments 129.60M USD = Net Debt Today 968.03M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 12.0%at most 5%passes32,498,310 / 31,868,549
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets12.5%at least -10.0%passes(329.65M USD − 62.93M USD) ÷ 2.14B USD
Price to bookMarket Cap ÷ Book Value Today2.40×at most 3×passes748.22M USD ÷ 312.22M USD
Operating marginOperating Income ÷ Revenue22.9%above 10.0%passes178.63M USD ÷ 781.35M USD
Revenue growthRevenue ÷ Revenue a Year Before − 123.6%above 10.0%passes781.35M USD / 632.08M USD
Net cash(Cash − Total Debt) ÷ Market Cap-129.4%above -30%does not pass(129.60M USD − 1.10B USD) ÷ 748.22M USD
Operating efficiencyOperating Income ÷ Gross Profit38.5%above 25.0%passes178.63M USD ÷ 463.72M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

23 USD

Enterprise value

1.84B USD

market cap plus net debt

EV / EBITDA

4.53×

Price / book

2.39×

the provider's book

Price / earnings

18.08×

Return on equity

17.6%

the provider's, not the engine's

Profit margin

5.9%

Revenue growth

6.3%

Analyst target, mean

49 USD

Analysts

8

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

464.40M567.33M632.08M781.35M

Gross profit

209.70M326.50M377.72M463.72M

Operating income

33.35M167.13M167.15M178.63M

EBITDA

operating income before depreciation and amortisation

173.48M308.64M342.04M401.41M

Pretax income

-28.88M75.81M98.67M92.71M

Net income

-25.03M48.20M69.26M62.93M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-25.03M63.17M75.17M73.00M

R&D

3.99M00—
Balance sheet, year end

Total assets

1.18B1.14B1.67B1.66B

Total liabilities

980.27M948.82M1.44B1.36B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

195.04M195.63M229.07M301.98M

Total debt

709.88M674.96M860.16M815.68M

Cash and equivalents

173.86M239.19M70.64M231.48M

Net PP&E

fixed assets after depreciation

26.41M22.03M20.17M16.22M

Working capital

current assets less current liabilities

-13.75M79.76M-27.28M251.63M
Cash flow

Operating cash flow

124.35M275.02M205.18M329.65M

Capital expenditure

paid out, so below zero

-1.62M-461.46K-1.65M-1.74M

Depreciation and amortisation

139.08M149.41M169.33M226.30M

Free cash flow

operating cash flow plus capital expenditure

122.73M274.56M203.53M327.91M